BEEASY CONSULTING SRLS

VIALE F. STROZZI, 30 - 50129 FIRENZE (ITALY) * VAT n.: IT07244890484 * REA REGISTRATION n.: FI–689983 * FULLY PAID COMPANY CAPITAL: € 5.000,00

f7dad71ac5866080104079e123d06b8799d53d5e

7476f9b4f9810f06604de00898d228528fca9724

UNLOCK THE FULL POTENTIAL OF YOUR RESEARCH
BY REMOVING UNCERTAINTY

COOKIE POLICY - PRIVACY POLICY - LEGAL POLICY (TERMS OF USE) - ACCESSIBILITY POLICY

"By failing to prepare, you are preparing to fail."

Benjamin Franklin

IS THERE A SINGLE DEFINITION OF "FEASIBILITY"?

In the realm of clinical studies, thorough preparation and strategic foresight serve as the cornerstones of success. Central to this preparation is the vital process of feasibility assessment, which evaluates the practicality, resources, and structure within the scope of the entire project. Feasibility is the backbone of any successful project - it identifies hurdles, fine-tunes strategies, and transforms plans into actionable pathways for impactful results.

The BeEasy feasibility process is a comprehensive, multi-dimensional review that encompasses 3 key stages within the clinical study process:

Program feasibility
Study feasibility
Site feasibility

This process involves analyzing the study design, timelines, recruitment potential, regulatory requirements, and logistical considerations to identify and address potential obstacles that could hinder progress. By proactively resolving these challenges, sponsors and researchers can allocate resources to high-impact projects while avoiding costly delays or setbacks.

27a14fdcd7fb618f158d184337ac010047369519

5f521fa502e1d2a55357ea9ff939ef0c2c2102da

WHY IS FEASIBILITY IMPORTANT?

Major pitfalls of clinical studies stemming from poor feasibility include:

Instead, a well-conducted feasibility assessment provides substantial benefits, including:

study design alignment with patients' availability, sites' resources and study objectives
higher compliance to study plans in terms of timelines, budget & scope
adherence to regulatory and logistical requirements for clinical studies
increase in study credibility and trust by the scientific & regulatory community

Patient Recruitment Challenges: insufficient analysis of patient availability can lead to difficulties in enrolling enough eligible participants, delaying the study or compromising its statistical power.
Underestimated Timelines: unrealistic timelines often result from inadequate feasibility assessments, causing significant delays in study execution and data collection.
Resource Misallocation: inefficient planning of resources - such as staff, equipment, or facilities - may lead to operational bottlenecks and increased costs.
Regulatory Setbacks: failure to account for local and international regulatory requirements can result in non-compliance, delaying approvals or halting the study altogether.
Site Selection Issues: choosing sites without proper feasibility evaluation can lead to operational inefficiencies, such as low patient enrollment or logistical challenges. Nearly one-third of sites performing clinical studies never enroll a single patient.
Budget Overruns: underestimating the financial requirements of the study due to a lack of feasibility evaluation may lead to unexpected expenses and funding shortfalls.
Logistical Barriers: poor feasibility assessment can overlook logistical complexities, including transportation of study materials or availability of specialized equipment.